Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein
- PMID: 15096050
- DOI: 10.1021/bi036135+
Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein
Abstract
Alpha-synuclein (alphaS) is a lipid-binding synaptic protein of unknown function that is found in an aggregated amyloid fibril form in the intraneuronal Lewy body deposits that are a defining characteristic of Parkinson's disease (PD). Although intrinsically unstructured when free in solution, alphaS adopts a highly helical conformation in association with lipid membranes or membrane mimetic detergent micelles. Two mutations in the alphaS gene have been linked to early onset autosomal dominant hereditary forms of PD, and have been shown to affect the aggregation kinetics of the protein in vitro. We have used high-resolution NMR spectroscopy, circular dichroism, and limited proteolysis to investigate the effects of these PD-linked mutations on the helical structure adopted by alphaS in the lipid or detergent micelle-bound form. We show that neither the A53T nor the A30P mutation has a significant effect on the structure of the folded protein, although the A30P mutation may cause a minor perturbation in the helical structure around the site of the mutation. The A30P, but not the A53T, mutation also appears to decrease the affinity of the protein for lipid surfaces, possibly by perturbing the nascent helical structure of the free protein. The potential implications of these results for the role of alphaS in PD are discussed.
Similar articles
-
Conformational properties of alpha-synuclein in its free and lipid-associated states.J Mol Biol. 2001 Apr 6;307(4):1061-73. doi: 10.1006/jmbi.2001.4538. J Mol Biol. 2001. PMID: 11286556
-
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.Biochemistry. 2000 Mar 14;39(10):2552-63. doi: 10.1021/bi991447r. Biochemistry. 2000. PMID: 10704204
-
Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.J Mol Biol. 2002 Jan 25;315(4):799-807. doi: 10.1006/jmbi.2001.5269. J Mol Biol. 2002. PMID: 11812148
-
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373. Mov Disord. 2013. PMID: 23390095 Review.
-
Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.Curr Protein Pept Sci. 2009 Oct;10(5):483-99. doi: 10.2174/138920309789351921. Curr Protein Pept Sci. 2009. PMID: 19538146 Free PMC article. Review.
Cited by
-
Semisynthetic and in Vitro Phosphorylation of Alpha-Synuclein at Y39 Promotes Functional Partly Helical Membrane-Bound States Resembling Those Induced by PD Mutations.ACS Chem Biol. 2016 Sep 16;11(9):2428-37. doi: 10.1021/acschembio.6b00539. Epub 2016 Jul 11. ACS Chem Biol. 2016. PMID: 27356045 Free PMC article.
-
Role of Lipids in the Pathogenesis of Parkinson's Disease.Int J Mol Sci. 2024 Aug 16;25(16):8935. doi: 10.3390/ijms25168935. Int J Mol Sci. 2024. PMID: 39201619 Free PMC article. Review.
-
The Role of Membrane Affinity and Binding Modes in Alpha-Synuclein Regulation of Vesicle Release and Trafficking.Biomolecules. 2022 Dec 5;12(12):1816. doi: 10.3390/biom12121816. Biomolecules. 2022. PMID: 36551244 Free PMC article.
-
The influence of vesicle size and composition on alpha-synuclein structure and stability.Biophys J. 2009 Apr 8;96(7):2857-70. doi: 10.1016/j.bpj.2008.12.3940. Biophys J. 2009. PMID: 19348768 Free PMC article.
-
Alpha synuclein modulates mitochondrial Ca2+ uptake from ER during cell stimulation and under stress conditions.NPJ Parkinsons Dis. 2023 Sep 23;9(1):137. doi: 10.1038/s41531-023-00578-x. NPJ Parkinsons Dis. 2023. PMID: 37741841 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous